Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,276 | -26,457 | -83,440 | -29,365 | 58,037 |
| Depreciation Amortization | 4,608 | 4,273 | 4,254 | 2,551 | 2,815 |
| Accounts receivable | 188 | -3,099 | 25 | -1,133 | 523 |
| Other Working Capital | -6,893 | 13,479 | 27,246 | 1,124 | -3,286 |
| Other Operating Activity | 1,015 | 4,062 | 41,921 | -5,275 | -82,373 |
| Operating Cash Flow | $-19,358 | $-7,742 | $-9,994 | $-32,098 | $-24,284 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -259 | 62 | -146 | -106 | 45 |
| PPE Investments | -627 | -686 | -968 | -829 | -461 |
| Other Investing Activity | 3 | 33 | -5 | -32 | 39,803 |
| Investing Cash Flow | $-883 | $-591 | $-1,119 | $-967 | $39,387 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 9,542 | 19,681 | N/A |
| Debt Repayment | N/A | -4,752 | -10,961 | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 14 | 6,635 |
| Financing Cash Flow | $N/A | $-4,752 | $-1,419 | $19,695 | $6,635 |
| Exchange Rate Effect | 225 | -270 | 414 | 277 | -131 |
| Beginning Cash Position | 37,808 | 51,163 | 63,281 | 76,374 | 54,767 |
| End Cash Position | 17,792 | 37,808 | 51,163 | 63,281 | 76,374 |
| Net Cash Flow | $-20,016 | $-13,355 | $-12,118 | $-13,093 | $21,607 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,358 | -7,742 | -9,994 | -32,098 | -24,284 |
| Capital Expenditure | -627 | -686 | -971 | -849 | -464 |
| Free Cash Flow | -19,985 | -8,428 | -10,965 | -32,947 | -24,748 |